Trial
NCT04596644
Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
New York State Psychiatric Institute
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Cannabis
Intervention
Active Cannabis
Why stopped
In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-08